Practical pharmacology. Part 1 презентация

Содержание

Слайд 2

What is pharmacology? It is science of the drugs pharma ology Drug Science

What is pharmacology?

It is science of the drugs

pharma

ology

Drug

Science

Слайд 3

What is Drug? It is the chemical that affect physiological body function through interaction with receptors

What is Drug?

It is the chemical that affect
physiological body function


through interaction with
receptors
Слайд 4

It is the chemical that affect physiological body function through interaction with receptors What is Drug?

It is the chemical that affect
physiological body function
through interaction

with
receptors

What is Drug?

Слайд 5

A Response

A

Response

Слайд 6

Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds

Forces involved in D-R interaction

Covalent bonds

Ionic bonds

Hydrogen bonds

Vander waals bonds

Слайд 7

Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds

Forces involved in D-R interaction

Covalent bonds

Ionic bonds

Hydrogen bonds

Vander waals bonds

Слайд 8

Forces involved in D-R interaction Covalent bonds Strong irreversible Alkylating agents

Forces involved in D-R interaction

Covalent bonds

Strong

irreversible

Alkylating agents

Слайд 9

Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds

Forces involved in D-R interaction

Covalent bonds

Ionic bonds

Hydrogen bonds

Vander waals bonds

Слайд 10

Forces involved in D-R interaction Ionic bonds common Affected by pH

Forces involved in D-R interaction

Ionic bonds

common

Affected by pH

Слайд 11

Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds

Forces involved in D-R interaction

Covalent bonds

Ionic bonds

Hydrogen bonds

Vander waals bonds

Слайд 12

Forces involved in D-R interaction Hydrogen bonds ?

Forces involved in D-R interaction

Hydrogen bonds

?

Слайд 13

Forces involved in D-R interaction Covalent bonds Ionic bonds Hydrogen bonds Vander waals bonds

Forces involved in D-R interaction

Covalent bonds

Ionic bonds

Hydrogen bonds

Vander waals bonds

Слайд 14

Forces involved in D-R interaction Vander waals bonds ?

Forces involved in D-R interaction

Vander waals bonds

?

Слайд 15

Receptors types On cell membrane Intracellular Receptor with intrinsic ion channel GPCR Enzyme linked receptors

Receptors types

On cell membrane

Intracellular

Receptor with intrinsic ion channel

GPCR

Enzyme linked receptors

Слайд 16

Receptors types On cell membrane Intracellular Transcription factors

Receptors types

On cell membrane

Intracellular

Transcription factors

Слайд 17

Слайд 18

Drug-Receptor Interaction D + R DR k1 K1 is association rate constant

Drug-Receptor Interaction

D

+

R

DR

k1

K1 is association rate constant

Слайд 19

Drug-Receptor Interaction D + R DR k2 K2 is dissociation rate constant

Drug-Receptor Interaction

D

+

R

DR

k2

K2 is dissociation rate constant

Слайд 20

Drug-Receptor Interaction D + R DR k1 k2 At equilibrium

Drug-Receptor Interaction

D

+

R

DR

k1

k2

At equilibrium

Слайд 21

Drug-Receptor Interaction [D] [R] [DR] k1 k2 = At equilibrium

Drug-Receptor Interaction

[D]

[R]

[DR]

k1

k2

=

At equilibrium

Слайд 22

Drug-Receptor Interaction [D] [R] [DR] k1 k2 = At equilibrium

Drug-Receptor Interaction

[D]

[R]

[DR]

k1

k2

=

At equilibrium

Слайд 23

Drug-Receptor Interaction k2 k1 = [R] [D] [DR] kd Kd

Drug-Receptor Interaction

k2

k1

=

[R]

[D]

[DR]

kd

Kd (dissociation equilibrium constant)
is conc. of the drug that


bind 50 % of the receptors
Слайд 24

kd It is a measure of drug affinity Its units

kd

It is a measure of drug affinity
Its units is conc. units

Drug

A

Drug B

Has higher Kd than

Which one has a higher affinity ?

Слайд 25

Important concepts Affinity Efficacy potency

Important concepts

Affinity
Efficacy
potency

Слайд 26

Affinity The ability of the drug to bind to the

Affinity

The ability of the drug to bind to the receptor
Measured by

Kd
Both agonist and antagonist have affinity to their receptors
Слайд 27

Efficacy It is the ability of the drugs to elicit

Efficacy

It is the ability of the drugs to elicit pharmacological effect
Measured

by Emax
Agonist has efficacy and antagonist has no efficacy
Слайд 28

potency The ability of the drug to produce response at lower conc. Measured by ED50

potency

The ability of the drug to produce response at lower conc.
Measured

by ED50
Слайд 29

The drug may be Agonist Antagonist Partial agonist

The drug may be

Agonist
Antagonist
Partial agonist

Слайд 30

Agonist Has affinity and efficacy IA=1

Agonist

Has affinity and efficacy
IA=1

Слайд 31

Antagonist Has affinity but no efficacy IA=0

Antagonist

Has affinity but no efficacy
IA=0

Слайд 32

Partial agonist Has affinity and efficacy IA=0-1

Partial agonist

Has affinity and efficacy
IA=0-1

Слайд 33

antagonism Physical Chemical Physiological Pharmacokinetic pharmacodynamic

antagonism

Physical
Chemical
Physiological
Pharmacokinetic
pharmacodynamic

Слайд 34

Chemical antagonism One drug reacts chemically with an active drug

Chemical antagonism
One drug reacts chemically with an active drug to form

an inactive compound,
It involves precipitation, complexation, neutralization redox reaction.
Intended ?treatment of heavy metal toxicity by complexation with chelators.
Incidental ? complexatin of tetracycline calcium in dairy products.
Слайд 35

Physiological antagonism 2 drugs act on different sites in the

Physiological antagonism
2 drugs act on different sites in the same or

different system.
a- Intended ? Norepinephrine in case of anaphylaxis.
b-Incidental ? patient taking barbiturates for anxiety, co-administration of anti-tussive (ephedrine).
Слайд 36

Pharmacokinetic antagonism (ADME) a- Intended ? forced alkaline diuresis in

Pharmacokinetic antagonism (ADME)
a- Intended ? forced alkaline diuresis in management of

barb Poisoning.
b- Incidental ? Barb. + other drugs
Induction of the metabolism of concomitant drugs, their decrease plasma level.
Слайд 37

Pharmacodynamic antagonist Competitive Non-competitive Reversible Surmountable antagonism Ach. + atropine

Pharmacodynamic antagonist

Competitive

Non-competitive

Reversible

Surmountable antagonism

Ach. + atropine

Слайд 38

Pharmacodynamic antagonist Competitive Non-competitive Irreversible Reversible Non-surmountable antagonism Ach. + succinylcholine

Pharmacodynamic antagonist

Competitive

Non-competitive

Irreversible

Reversible

Non-surmountable antagonism

Ach. + succinylcholine

Слайд 39

An A X

An

A

X

Слайд 40

A X An

A

X

An

Слайд 41

Dose-Response Curve What ? Types ?

Dose-Response Curve

What ?
Types ?

Слайд 42

Dose Response Hyperbolic curve

Dose

Response

Hyperbolic curve

Слайд 43

Log dose Response Sigmoidal shaped curve

Log dose

Response

Sigmoidal shaped curve

Слайд 44

Log dose Response Linear

Log dose

Response

Linear

Слайд 45

Log dose Response Wide range of doses

Log dose

Response

Wide range of doses

Слайд 46

Log dose Response ED50 can be calculated ED50

Log dose

Response

ED50 can be calculated

ED50

Слайд 47

Graded DRC Depends on graded response ED50 ? The dose that give 50% of maximal response

Graded DRC

Depends on graded response
ED50 ?

The dose that give 50% of

maximal response
Слайд 48

Log dose Response ED50 50%

Log dose

Response

ED50

50%

Слайд 49

Quantal DRC Depends on quantal response ED50 ? The dose

Quantal DRC

Depends on quantal response
ED50 ?

The dose that give response in

50% of population
Слайд 50

Log dose %Response ED50 50%

Log dose

%Response

ED50

50%

Слайд 51

ED50 Compare between potencies of two drugs Drug A Drug

ED50

Compare between potencies of two drugs

Drug A

Drug B

Has higher ED50 than

Which

one is more potent ?
Слайд 52

ED50 Calculation of the therapeutic index TI LD50 = Is a measure of drug safety ED50

ED50

Calculation of the therapeutic index

TI

LD50

=

Is a measure of drug safety

ED50

Слайд 53

Log dose Response ED50 50% LD50 TI

Log dose

Response

ED50

50%

LD50

TI

Слайд 54

Log dose Response ED50 50% LD50 TI

Log dose

Response

ED50

50%

LD50

TI

Слайд 55

Drug A Drug B Has higher TI than Which one is more safer ?

Drug A

Drug B

Has higher TI than

Which one is more safer ?

Слайд 56

DRC & antagonists Competitive reversible antagonist Log dose Response

DRC & antagonists

Competitive reversible antagonist

Log dose

Response

Слайд 57

DRC & antagonists Competitive irreversible antagonist Log dose Response

DRC & antagonists

Competitive irreversible antagonist

Log dose

Response

Слайд 58

DRC & antagonists non-competitive antagonist Log dose Response

DRC & antagonists

non-competitive antagonist

Log dose

Response

Слайд 59

Important notes Parrallism Indicate competition

Important notes

Parrallism

Indicate competition

Слайд 60

Important notes Emax Indicate reversibility

Important notes

Emax

Indicate reversibility

Имя файла: Practical-pharmacology.-Part-1.pptx
Количество просмотров: 38
Количество скачиваний: 0